GGrantIndex
← Leaderboards

Ronald Scott Braithwaite

Yale University

Google Scholar ↗PubMed ↗ORCID ↗
$34,131,274
Attributed
$36,146,915
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.3M · FY2007–25
$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,750,398 · 13
CDC$3,287,881 · 1
AHRQ$2,108,636 · 1

By mechanism

R01$23,031,203 · 8
U24$3,412,896 · 1
U48$3,287,881 · 1
K12$2,108,636 · 1
U01$2,083,544 · 1
R34$900,444 · 1

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Caring”

Research focus

CaringPersonsResourcesBaseFundingIncidenceAlcoholsCollaborationsOperations ResearchCostMortalityAcquired Immunodeficiency SyndromeMorbidity - Disease RateEpidemicMathematical ModelCharacteristicsLinkHiv InfectionsInfectionUnited StatesPharmaceutical PreparationsPreventHealthcarePolicies

Grant awards (67)

Are Ending the HIV Epidemic goals attainable across race/ethnic groups, risk groups, and settings?$786,943
R01 · FY2025 · AA · contact PI
Are Ending the HIV Epidemic goals attainable across race/ethnic groups, risk groups, and settings?$820,845
R01 · FY2024 · AA · contact PI
Can a radical transformation of preventive care reduce mortality by 20% in low SES populations? Preparatory work focusing on AUD/heavy alcohol use, HIV risk, and cardiovascular risk$243,656
R34 · FY2024 · AA · contact PI
Can a radical transformation of preventive care reduce mortality by 20% in low SES populations? Preparatory work focusing on AUD/heavy alcohol use, HIV risk, and cardiovascular risk$169,476
R34 · FY2024 · AA · contact PI
Could long-acting medications facilitate "ending AIDS by 2030" in southern Africa? An allocative efficiency analysis$666,898
R01 · FY2023 · AA · contact PI
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal$531,609
R01 · FY2023 · AA · contact PI
Can a radical transformation of preventive care reduce mortality by 20% in low SES populations? Preparatory work focusing on AUD/heavy alcohol use, HIV risk, and cardiovascular risk$286,031
R34 · FY2023 · AA · contact PI
Could long-acting medications facilitate "ending AIDS by 2030" in southern Africa? An allocative efficiency analysis$682,242
R01 · FY2022 · AA · contact PI
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons$620,560
R01 · FY2022 · DA · contact PI
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal$574,865
R01 · FY2022 · AA · contact PI
Can a radical transformation of preventive care reduce mortality by 20% in low SES populations? Preparatory work focusing on AUD/heavy alcohol use, HIV risk, and cardiovascular risk$201,281
R34 · FY2022 · AA · contact PI
Could long-acting medications facilitate "ending AIDS by 2030" in southern Africa? An allocative efficiency analysis$702,655
R01 · FY2021 · AA · contact PI
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons$641,983
R01 · FY2021 · DA · contact PI
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal$589,949
R01 · FY2021 · AA · contact PI
Could long-acting medications facilitate "ending AIDS by 2030" in southern Africa? An allocative efficiency analysis$724,289
R01 · FY2020 · AA · contact PI
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$666,609
R01 · FY2020 · AA · contact PI
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons$656,266
R01 · FY2020 · DA · contact PI
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal$611,348
R01 · FY2020 · AA · contact PI
4/6 COMpAAAS U01: Operations Research Study$197,206
U01 · FY2020 · AA · contact PI
Could long-acting medications facilitate “ending AIDS by 2030” in southern Africa? An allocative efficiency analysis$813,628
R01 · FY2019 · AA · contact PI
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$678,852
R01 · FY2019 · AA · contact PI
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons$670,549
R01 · FY2019 · DA · contact PI
From 90-90-90 to 95-95-95 and beyond: Optimizing and targeting combination HIV prevention for Zimbabwe and Kwazulu Natal$665,255
R01 · FY2019 · AA · contact PI
4/6 COMpAAAS U01: Operations Research Study$197,206
U01 · FY2019 · AA · contact PI
Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons$714,928
R01 · FY2018 · DA · contact PI
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$701,784
R01 · FY2018 · AA · contact PI
4/6 COMpAAAS U01: Operations Research Study$197,206
U01 · FY2018 · AA · contact PI
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$99,841
R01 · FY2018 · AA · contact PI
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$720,598
R01 · FY2017 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$416,472
R01 · FY2017 · CA
Comparative Effectiveness Research Core$225,424
P30 · FY2017 · DA · contact PI
4/6 COMpAAAS U01: Operations Research Study$197,206
U01 · FY2017 · AA · contact PI
Discovering the Value of Imaging: A Collaborative Training Program in Biomedical Big Data and Comparative Effectiveness Research for the Field of Radiology$167,633
R25 · FY2017 · EB
Should screening and treatment strategies for unhealthy alcohol misuse in HIV-infected persons vary with smoking, depression, and substance abuse?$760,178
R01 · FY2016 · AA · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$647,525
U24 · FY2016 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$420,665
R01 · FY2016 · CA
4/6 COMpAAAS U01: Operations Research Study$198,972
U01 · FY2016 · AA · contact PI
Discovering the Value of Imaging: A Collaborative Training Program in Biomedical Big Data and Comparative Effectiveness Research for the Field of Radiology$168,069
R25 · FY2016 · EB
Comparative Effectiveness Research Core$162,011
P30 · FY2016 · DA · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$84,185
U24 · FY2016 · AA · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$645,905
U24 · FY2015 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$446,246
R01 · FY2015 · CA
Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use$218,249
U01 · FY2015 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$178,343
R01 · FY2015 · CA
Discovering the Value of Imaging: A Collaborative Training Program in Biomedical Big Data and Comparative Effectiveness Research for the Field of Radiology$168,491
R25 · FY2015 · EB
Implementation science to optimize HIV prevention in East Africa PEPFAR programs.$883,496
R01 · FY2014 · AI · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$666,027
U24 · FY2014 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$483,682
R01 · FY2014 · CA
Comparative Effectiveness Research Core$236,363
P30 · FY2014 · DA · contact PI
Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use$218,250
U01 · FY2014 · AA · contact PI
Implementation science to optimize HIV prevention in East Africa PEPFAR programs.$883,496
R01 · FY2013 · AI · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$651,424
U24 · FY2013 · AA · contact PI
Benefits and Harms of Lung Cancer Screening in HIV Infection$573,861
R01 · FY2013 · CA
Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use$209,249
U01 · FY2013 · AA · contact PI
Comparative Effectiveness Research Core$194,320
P30 · FY2013 · DA · contact PI
Implementation science to optimize HIV prevention in East Africa PEPFAR programs.$889,221
R01 · FY2012 · AI · contact PI
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA$717,830
U24 · FY2012 · AA · contact PI
Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use$225,000
U01 · FY2012 · AA · contact PI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a$434,639
R01 · FY2011 · AA · contact PI
Consortium to improve Outcomes in HIV/AIDS, Alcohol, Aging & multi-Substance use$225,000
U01 · FY2011 · AA · contact PI
NYU PREVENTION RESEARCH CENTER: COMPARATIVE EFFECTIVENESS RESEARCH PROGRAM$3,287,881
U48 · FY2010 · DP · contact PI
Mentored Career Development in Comparative Effectiveness Research$2,108,636
K12 · FY2010 · HS · contact PI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a$497,719
R01 · FY2010 · AA · contact PI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a$435,958
R01 · FY2010 · AA · contact PI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a$540,159
R01 · FY2009 · AA · contact PI
A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit a$458,046
R01 · FY2008 · AA · contact PI
A computer simulation of the Sub-Saharan HIV pandemic$386,526
R01 · FY2007 · AA · contact PI